Brazil appraises "first push" at Chinese medtech market
This article was originally published in Clinica
Seven Brazilian medtech firms went last month to China, as part of a government-organised trade mission. The trip was described by Brazilian industry association ABIMO as a "first push" to secure a share of the US$2.6bn which the Chinese spend on medical equipment imports.
You may also be interested in...
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.